Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions
- 18 December 2018
- journal article
- research article
- Published by Taylor & Francis in Platelets
- Vol. 30 (1) , 126-135
Abstract
Human platelets express two protease-activated receptors (PARs), PAR1 (F2R) and PAR4 (F2RL3), which are activated by a number of serine proteases that are generated during pathological events and cause platelet activation. Recent interest has focused on PAR4 as a therapeutic target, given PAR4 seems to promote experimental thrombosis and procoagulant microparticle formation, without a broadly apparent role in hemostasis. However, it is not yet known whether PAR4 activity plays a role in platelet-leukocyte interactions, which are thought to contribute to both thrombosis and acute or chronic thrombo-inflammatory processes. We sought to determine whether PAR4 activity contributes to granule secretion from activated platelets and platelet-leukocyte interactions. We performed in vitro and ex vivo studies of platelet granule release and platelet-leukocyte interactions in the presence of PAR4 agonists including PAR4 activating peptide, thrombin, cathepsin G, and plasmin in combination with small-molecule PAR4 antagonists. Activation of human platelets with thrombin, cathepsin G, or plasmin potentiated platelet dense granule secretion that was specifically impaired by PAR4 inhibitors. Platelet-leukocyte interactions and platelet P-selectin exposure the following stimulation with PAR4 agonists were also impaired by activated PAR4 inhibition in either a purified system or in whole blood. These results indicate PAR4-specific promotion of platelet granule release and platelet-leukocyte aggregate formation and suggest that pharmacological control of PAR4 activity could potentially attenuate platelet granule release or platelet-leukocyte interaction-mediated pathological processes.Keywords
Funding Information
- American Heart Association (13EIA12630000,17SDG33350075)
- National Institutes of Health (R01GM116184,R01HL101972,R01HL133923,R21HD16037,T32AI007472)
This publication has 45 references indexed in Scilit:
- Platelet secretion in inflammatory and infectious diseasesPlatelets, 2016
- Protease-activated Receptor-4 Signaling and Trafficking Is Regulated by the Clathrin Adaptor Protein Complex-2 Independent of β-ArrestinsJournal of Biological Chemistry, 2016
- Protease-activated receptors in hemostasisBlood, 2016
- Platelet secretion: From haemostasis to wound healing and beyondBlood Reviews, 2015
- Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human PlateletsMolecular Pharmacology, 2013
- Platelet Dense-Granule Secretion Plays a Critical Role in Thrombosis and Subsequent Vascular Remodeling in Atherosclerotic MiceCirculation, 2009
- Interaction of Thrombin with PAR1 and PAR4 at the Thrombin Cleavage SiteBiochemistry, 2007
- Protease-activated receptor signalling, endocytic sorting and dysregulation in cancerJournal of Cell Science, 2007
- Role of the PAR4 Thrombin Receptor in Stabilizing Platelet-platelet Aggregates as Revealed by a Patient with Hermansky-Pudlak SyndromeThrombosis and Haemostasis, 2002
- Domains specifying thrombin–receptor interactionNature, 1991